{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "# Load environment variables from .env file\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "openai_api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "https://github.com/microsoft/autogen/blob/main/notebook/agentchat_groupchat_stateflow.ipynb - see here for examples of coder and paper summariser agent\n",
    "\n",
    "1. initialiser (GC manager)\n",
    "2. Coder - get papers API (why is it a coder)\n",
    "3. Execute the code? - human input \n",
    "4. Scientist read the papers and write a summary\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import autogen\n",
    "\n",
    "load_dotenv() \n",
    "\n",
    "openai_api_key = os.getenv(\"OPENAI_API_KEY\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import autogen\n",
    "import os\n",
    "\n",
    "# Get the API key from environment variable\n",
    "openai_api_key = os.environ.get(\"OPENAI_API_KEY\")\n",
    "\n",
    "# Load the config list from JSON\n",
    "config_list = autogen.config_list_from_json(\n",
    "    \"OA_config_list.json\",\n",
    "    filter_dict={\"model\": [\"gpt-4\"]}\n",
    ")\n",
    "\n",
    "# Add the API key to each config in the list\n",
    "for config in config_list:\n",
    "    config[\"api_key\"] = openai_api_key"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "import tempfile\n",
    "from autogen.coding import LocalCommandLineCodeExecutor\n",
    "from autogen import GroupChat\n",
    "from APIs.pubmed import PubMedAPI # Import the PubMedAPI class for literature search\n",
    "\n",
    "\n",
    "pubmed_api =PubMedAPI(email=\"sanazkazemi@hotmail.com\") # for enterez to contact you if neccessary\n",
    "\n",
    "def use_pubmed_api(query, max_results=10):\n",
    "    # doc string needs to be absolutely comprehensive\n",
    "    \"\"\"\n",
    "    Use the PubMed API to search for articles related to the given query.\n",
    "\n",
    "    Args:\n",
    "        query (str): The query string to search for.\n",
    "        max_results (int): The maximum number of results to return.\n",
    "\n",
    "    Returns:\n",
    "        list: A list of article titles and abstracts.\n",
    "    \"\"\"\n",
    "    # Search for articles related to the query\n",
    "    articles = pubmed_api.search(query, max_results=max_results)\n",
    "\n",
    "    # Extract the titles and abstracts from the articles\n",
    "    results = []\n",
    "    for article in articles:\n",
    "        title = article.get(\"title\", \"\")\n",
    "        abstract = article.get(\"abstract\", \"\")\n",
    "        results.append({\"title\": title, \"abstract\": abstract})\n",
    "\n",
    "    return results\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "temp_dir = tempfile.TemporaryDirectory()\n",
    "executor = LocalCommandLineCodeExecutor(\n",
    "    timeout=10,  # Timeout for each code execution in seconds.\n",
    "    work_dir=temp_dir.name,  # Use the temporary directory to store the code files.\n",
    ")\n",
    "\n",
    "gpt4_config = {\n",
    "    \"cache_seed\": False,  # change the cache_seed for different trials\n",
    "    \"temperature\": 0,\n",
    "    \"config_list\": config_list,\n",
    "    \"timeout\": 120,\n",
    "}\n",
    "\n",
    "Moderator = autogen.UserProxyAgent(\n",
    "    name=\"Moderator\",\n",
    "    code_execution_config=False,\n",
    "    human_input_mode=\"NEVER\",\n",
    "    system_message=\"\"\"\n",
    "                    You are the Moderator. You receive prompts from the \n",
    "                    human and coordinate the discussion between the other \n",
    "                    agents. After receiving input from all agents, you summarize \n",
    "                    and present the final output.\"\"\",)\n",
    "\n",
    "\n",
    "scientific_rational = autogen.AssistantAgent(\n",
    "    name=\"Scientific_Rational\",\n",
    "    llm_config=config_list[0],\n",
    "    system_message=\"\"\"You provide scientific reasoning and explanations for the given \n",
    "                    prompt using articles and evidence. You reference the sources and \n",
    "                    provide a summary of the key points.\"\"\",)\n",
    "\n",
    "\n",
    "safety_officer = autogen.AssistantAgent(\n",
    "    name=\"Safety_Assistant\",\n",
    "    system_message=\"\"\"You are the safety assistant. You ensure that the chosen drug target is safe for human use. \n",
    "                    You provide a safety assessment of the drug target and suggest any necessary modifications.\",)\n",
    "                     human_input_mode=\"NEVER\"\"\",\n",
    "    llm_config=config_list[0],\n",
    ")\n",
    "target_assessment = autogen.AssistantAgent(\n",
    "    name=\"Target_Assessment\",\n",
    "    llm_config=config_list[0],\n",
    "    system_message=\"\"\"You develop strategies to assess and evaluate the target or goal mentioned in the prompt. \n",
    "                    You Provide a detailed plan for the assessment and evaluation of the target.\"\"\",\n",
    ")\n",
    "\n",
    "literature_agent = autogen.AssistantAgent(\n",
    "    name=\"Literature_Agent\",\n",
    "    llm_config=config_list[0],\n",
    "    system_message=\"\"\"You provide relevant literature and references related to the prompt. \n",
    "                    You summarize the key points and provide a list of references.\"\"\",\n",
    ")\n",
    "\n",
    "def state_transition(last_speaker, groupchat):\n",
    "    if last_speaker == Moderator:\n",
    "        return scientific_rational\n",
    "    elif last_speaker == scientific_rational:\n",
    "        return safety_officer\n",
    "    elif last_speaker == safety_officer:\n",
    "        return target_assessment\n",
    "    elif last_speaker == target_assessment:\n",
    "        return Moderator\n",
    "    else:\n",
    "        return None\n",
    "\n",
    "Moderator.description = \"Coordinate discussion between agents, summarize inputs, and present final output.\"\n",
    "scientific_rational.description = \"Provide scientific reasoning and explanations for the given prompt.\"\n",
    "safety_officer.description = \"Assess potential safety concerns and ethical implications related to the prompt.\"\n",
    "target_assessment.description = \"Develop strategies to assess and evaluate the target or goal mentioned in the prompt.\"\n",
    "literature_agent.description = \"Provide relevant literature and research references related to the prompt.\"\n",
    "\n",
    "groupchat = autogen.GroupChat(\n",
    "    agents=[Moderator, scientific_rational, safety_officer, target_assessment],\n",
    "    messages=[],\n",
    "    max_round=10,\n",
    "    speaker_selection_method=state_transition,\n",
    "    send_introductions=True,\n",
    ")\n",
    "manager = autogen.GroupChatManager(groupchat=groupchat, llm_config=config_list[0])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[33mModerator\u001b[0m (to chat_manager):\n",
      "\n",
      "what can you tell me about ACE inhibitors and their side effects? How can we assess the safety of ACE inhibitors?\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Scientific_Rational\n",
      "\u001b[0m\n",
      "\u001b[33mScientific_Rational\u001b[0m (to chat_manager):\n",
      "\n",
      "ACE inhibitors (Angiotensin-Converting-Enzyme inhibitors) are a class of medications mainly used to treat high blood pressure, heart failure, and other heart conditions. They work by relaxing blood vessels and reducing the volume of blood the heart must pump, thus decreasing the heart's workload.\n",
      "\n",
      "The known side effects of ACE inhibitors include:\n",
      "\n",
      "1. Dry cough: A persistent dry cough is a common side effect of ACE inhibitors. This occurs because ACE inhibitors cause a build-up of bradykinin, a peptide that causes blood vessels to dilate. However, in the lungs, it can stimulate cough reflexes and cause a dry cough.\n",
      "\n",
      "2. Renal dysfunction: ACE inhibitors can lead to an increase in creatinine levels, indicating impaired kidney function. They should be used with caution in patients with existing kidney disease.\n",
      "\n",
      "3. Hyperkalemia: ACE inhibitors can cause high potassium levels in the blood due to decreased renal excretion of potassium. \n",
      "\n",
      "4. Hypotension: Especially encountered after the initial doses, ACE inhibitors can cause low blood pressure.\n",
      "\n",
      "5. Angioedema: Although rare, this life-threatening swelling of the throat and mouth can occur with ACE inhibitor use.\n",
      "\n",
      "Determining the safety of ACE inhibitors involves a risk-benefit analysis by clinicians and careful patient monitoring. Blood pressure, kidney function (serum creatinine), and serum potassium levels should be checked before starting therapy and periodically thereafter. Attention to the patient's hydration status and concurrent medications also helps to mitigate harmful effects.\n",
      "\n",
      "For more detailed information about ACE inhibitors, you can refer to these sources:\n",
      "\n",
      "- Mayo Clinic (2020). ACE inhibitors. https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/ace-inhibitors/art-20047480\n",
      "- MedlinePlus (2021). ACE inhibitors. https://medlineplus.gov/druginfo/meds/a692027.html\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Safety_Assistant\n",
      "\u001b[0m\n",
      "\u001b[33mSafety_Assistant\u001b[0m (to chat_manager):\n",
      "\n",
      "As a safety assistant, I can provide additional comments on the safety measures for ACE inhibitors by pointing out potential interactions and precautions needed before starting therapy.\n",
      "\n",
      "1. Patient's Medical History: It is crucial to take a thorough medical history of the patient, including previous medications, allergies, and health conditions. ACE inhibitors, for instance, should be used with caution in individuals with a history of angioedema, renal artery stenosis or advanced kidney disease.\n",
      "\n",
      "2. Drug Interactions: ACE inhibitors can interact with other medications like NSAIDs, diuretics, or drugs resultant in raised potassium levels which can exacerbate the risk of renal impairment or cause hyperkalemia.\n",
      "\n",
      "3. Dose Adjustments: Close monitoring and dose adjustments may be necessary in individuals with liver disease, older adults, or those with a low-sodium diet, due to the increased risk of hypotension.\n",
      "\n",
      "4. Pregnancy Considerations: ACE inhibitors are not recommended during pregnancy. If a patient becomes pregnant while taking an ACE inhibitor, the drug should be stopped as soon as possible and switched to a different class of medication.\n",
      "\n",
      "5. Monitoring: Continuous monitoring of the patient's blood pressure, renal function, and blood electrolyte levels can help detect any adverse effects early and manage them effectively.\n",
      "\n",
      "Remember, while ACE inhibitors are indeed beneficial and commonly used in clinical practice, they come with potential side effects that require close monitoring and proper patient education to ensure safe use. It is important to assess each patient individually against the potential benefits and drawbacks related to the use of ACE inhibitors. This will assist in providing the best care for the patient. Safety is always a top priority.\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Target_Assessment\n",
      "\u001b[0m\n",
      "\u001b[33mTarget_Assessment\u001b[0m (to chat_manager):\n",
      "\n",
      "Here is how we can develop strategies to assess and evaluate the safety of ACE inhibitors:\n",
      "\n",
      "1. Clinical Guidelines: Develop and use comprehensive clinical guidelines on the use of ACE inhibitors. These guidelines should help healthcare professionals understand when to prescribe these drugs, common side effects to watch out for, and how to manage those side effects.\n",
      "\n",
      "2. Educational Programs: Develop educational programs for healthcare professionals about ACE inhibitors. This should emphasize the importance of patient education, as patients who are aware of potential side effects can report them early, resulting in quicker response and treatment.\n",
      "\n",
      "3. Patient Monitoring: Implement a systematic patient monitoring strategy. Patients taking ACE inhibitors should have regular follow-ups. Their blood pressure, kidney function, and serum potassium levels should be monitored closely. Monitoring schedules should be flexible based on patients' needs and responses.\n",
      "\n",
      "4. Adverse Event Reporting System: Implement a robust adverse event reporting system. Prompt documentation and reporting of adverse events will facilitate quick action and may lead to new insights about the safety and effectiveness of ACE inhibitors.\n",
      "\n",
      "5. Research: Contribute to research on ACE inhibitors. Clinical trials and observational studies can further our understanding of these drugs. These studies can also inform guideline development and policy-making.\n",
      "\n",
      "6. Review and Update: Regularly review and update guidelines, educational programs, and patient monitoring systems according to the latest evidence and discoveries.\n",
      "\n",
      "Using these strategies, we can continually assess and evaluate the safety of ACE inhibitors, ensuring these drugs bring more benefits than harm to patients. The target here is to ensure that the administration of ACE inhibitors is done in the safest way possible for the welfare of the patient.\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Moderator\n",
      "\u001b[0m\n",
      "\u001b[33mModerator\u001b[0m (to chat_manager):\n",
      "\n",
      "\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Scientific_Rational\n",
      "\u001b[0m\n",
      "\u001b[33mScientific_Rational\u001b[0m (to chat_manager):\n",
      "\n",
      "Given the input from our team, here's a synthesized response to your question:\n",
      "\n",
      "ACE inhibitors are a class of medications vital to the treatment of conditions like hypertension and heart failure. Known side effects, as mentioned, can range from a lingering dry cough to more serious conditions such as kidney dysfunction and potentially life-threatening angioedema. Detailed information can be found in the sources provided by Scientific_Rational, including Mayo Clinic and MedlinePlus.\n",
      "\n",
      "Safety_Assistant emphasised the importance of assessing each patient's medical history, potential drug interactions, necessary dose adjustments, and the contraindication of ACE inhibitors in pregnancy. Continuous patient monitoring makes early detection and management of any adverse effects possible.\n",
      "\n",
      "To further evaluate the safety of ACE inhibitors, Target_Assessment suggested creating comprehensive clinical guidelines and educational programs for healthcare professionals. A systematic approach to patient monitoring and a robust adverse events reporting system can allow for prompt action and better understanding of these drugs. Furthermore, contributions to research and regular updates based on the latest findings can ensure improved practices and enhance patient safety.\n",
      "\n",
      "In summary, while ACE inhibitors are an important part of cardiovascular treatment, their use calls for careful consideration of potential side effects, regular patient monitoring and a continuous commitment to understanding their impacts better.\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Safety_Assistant\n",
      "\u001b[0m\n",
      "\u001b[33mSafety_Assistant\u001b[0m (to chat_manager):\n",
      "\n",
      "The analysis provided by the Scientific_Rational and Target_Assessment is indeed comprehensive. On top of that, I would like to highlight a few additional points to ensure patient safety:\n",
      "\n",
      "1. Perhaps the most crucial measure to prevent undesired effects is educating the patient about potential side effects and what actions to take if they occur. For example, any sign of angioedema (such as swelling of the lips, tongue, or throat) should be treated as an emergency and they should seek immediate medical help.\n",
      "   \n",
      "2. Further, patients should be advised not to take potassium supplements or use salt substitutes that contain potassium without consulting their healthcare provider, as ACE inhibitors can increase blood potassium levels.\n",
      "   \n",
      "3. It's equally important to coordinate with other healthcare providers involved in the patient's care. For example, if the patient is also seeing a kidney specialist or an endocrinologist who prescribes drugs that may affect kidney function or potassium levels in the blood. \n",
      "\n",
      "4. Additionally, considering dose schedules and adherence, patients might forget to take their medication, so pharmacist consultation is valuable for advice on techniques to help remember or to use compliance aids.\n",
      "\n",
      "5. Lastly, there should be a clear workflow for monitoring and follow-up of the patients. Regular laboratory tests to measure blood pressure and blood tests to monitor kidney function and potassium levels need to be organized according to risk factors. \n",
      "\n",
      "Remember, safe medication use is about more than just receiving a prescription and taking pills. It requires a full-circle approach involving healthcare providers, scientific information, and patient participation. This allows for the best patient care with optimal outcomes.\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Target_Assessment\n",
      "\u001b[0m\n",
      "\u001b[33mTarget_Assessment\u001b[0m (to chat_manager):\n",
      "\n",
      "To assess the safety of ACE inhibitors in a systematic manner, the strategies developed can take the form of a detailed plan as follows:\n",
      "\n",
      "Stage 1: Patient Profile Analysis\n",
      "During this stage, thorough medical history, ongoing medications, allergic reactions, etc., of the patient should be evaluated. This extraverted information will help in determining potential risks like drug-protein interactions, hypersensitivity, and other genetic or lifestyle factors inducing adverse effects.\n",
      "\n",
      "Stage 2: Prescription Analysis\n",
      "While the ACE inhibitors are being prescribed, any potential interaction with the patient's current drugs must be evaluated. Their contraindications in conditions like kidney failure, pregnancy, and their adjustment in patients with hepatic diseases or elderly patients should be accounted for.\n",
      "\n",
      "Stage 3: Patient Monitoring \n",
      "After the drug has been prescribed, the patient should be monitored at regular intervals. This helps in the timely detection of any adverse events and proper management of the same. The monitoring process includes regular checks for blood pressure levels, kidney function (serum creatinine) and potassium levels, and signs of any allergic reactions.\n",
      "\n",
      "Stage 4: Adverse Event Reporting Systems & Database Management\n",
      "An efficient system for reporting adverse events leads to swift action, reduces patient harm, and maintains a valuable database for future reference. The practitioners should be trained to promptly document and report any adverse events observed.\n",
      "\n",
      "Stage 5: Updating Medical Knowledge\n",
      "The medical professionals should be continuously educated about the advanced findings related to the safety and efficacy of ACE inhibitors. This can be achieved by making updated guidelines, training programs, workshops, etc., easily available to them. \n",
      "\n",
      "Throughout this process, the primary aim should be patient safety and reducing the harm to the minimum. Regularly revisiting the steps of these strategies ensures their continual relevance and effectiveness, and offers the best care to the patient. \n",
      "\n",
      "The evaluation of these strategies can be performed by periodic audits in which the adherence to the stages of the plan is checked. Furthermore, the correlation between the implementation of these strategies and the decrease in the number of adverse events can be tracked and analyzed. This will provide quantitative data for the performance evaluation of the devised strategies and hence, provide areas of improvement.\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Moderator\n",
      "\u001b[0m\n",
      "\u001b[33mModerator\u001b[0m (to chat_manager):\n",
      "\n",
      "\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "\u001b[32m\n",
      "Next speaker: Scientific_Rational\n",
      "\u001b[0m\n",
      "\u001b[33mScientific_Rational\u001b[0m (to chat_manager):\n",
      "\n",
      "Having heard from our team, we can outline a cohesive response:\n",
      "\n",
      "ACE inhibitors, crucial for conditions like hypertension and heart failure, have side effects ranging from a persistent dry cough to serious issues like renal dysfunction and angioedema (Mayo Clinic, MedlinePlus). \n",
      "\n",
      "The Safety_Assistant stressed the need for a comprehensive patient history, possible drug interactions, dose adjustments, and the contraindication of ACE inhibitors in pregnancy. Additional safety measures include educating the patient about potential side effects and actions required in case they occur, advising against unmonitored intake of potassium supplements, coordinating with other healthcare providers involved with the patient and arranging a clear workflow for patient monitoring and follow-up. Medication safety involves healthcare providers, scientific data, and direct patient participation in full circle.\n",
      "\n",
      "The Target_Assessment outlines a systematic strategy for evaluating ACE inhibitors safety, which includes analyzing patients' profiles, prescriptions, careful monitoring, and robust adverse event reporting systems. Furthermore, they suggest regularly updating healthcare professionals' knowledge on ACE inhibitors safety and effectiveness, and evaluating the outlined strategies by performing periodic audits.\n",
      "\n",
      "Therefore, while ACE inhibitors are an essential part of cardiovascular treatment, careful consideration of potential side effects, regular patient monitoring, and commitment to continuous understanding enhance their impacts towards safer and improved clinical outcomes.\n",
      "\n",
      "--------------------------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "chat_result = Moderator.initiate_chat(\n",
    "    manager, message=\"what can you tell me about ACE inhibitors and their side effects? How can we assess the safety of ACE inhibitors?\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Having heard from our team, we can outline a cohesive response:\n",
      "\n",
      "ACE inhibitors, crucial for conditions like hypertension and heart failure, have side effects ranging from a persistent dry cough to serious issues like renal dysfunction and angioedema (Mayo Clinic, MedlinePlus). \n",
      "\n",
      "The Safety_Assistant stressed the need for a comprehensive patient history, possible drug interactions, dose adjustments, and the contraindication of ACE inhibitors in pregnancy. Additional safety measures include educating the patient about potential side effects and actions required in case they occur, advising against unmonitored intake of potassium supplements, coordinating with other healthcare providers involved with the patient and arranging a clear workflow for patient monitoring and follow-up. Medication safety involves healthcare providers, scientific data, and direct patient participation in full circle.\n",
      "\n",
      "The Target_Assessment outlines a systematic strategy for evaluating ACE inhibitors safety, which includes analyzing patients' profiles, prescriptions, careful monitoring, and robust adverse event reporting systems. Furthermore, they suggest regularly updating healthcare professionals' knowledge on ACE inhibitors safety and effectiveness, and evaluating the outlined strategies by performing periodic audits.\n",
      "\n",
      "Therefore, while ACE inhibitors are an essential part of cardiovascular treatment, careful consideration of potential side effects, regular patient monitoring, and commitment to continuous understanding enhance their impacts towards safer and improved clinical outcomes.\n"
     ]
    }
   ],
   "source": [
    "print(chat_result.summary)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "LLM_agent",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
